Humira sBLA Submitted For Ankylosing Spondylitis
This article was originally published in The Pink Sheet Daily
Executive Summary
Abbott filed a supplemental BLA with FDA seeking approval of the TNF-inhibitor Humira (adalimumab) as a treatment for ankylosing spondylitis Oct. 4